CFDE Data Portal | Search VN1R110P

	Label	Description
	VN1R110P associations Collection (Entity type)	Associations for VN1R110P_associations
	VN1R110P associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	VN1R110P Gene (Entity type)	ENSG00000231725 - vomeronasal 1 receptor 110 pseudogene
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE190076 H-7 Huh-7 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226525 GSE226527 HNRNPH2 knockout 4 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 azacitidine 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

VN1R110P associations

Associations for VN1R110P_associations

VN1R110P associations.tsv

A file from IDG as part of the Harmonizome project

VN1R110P

ENSG00000231725 - vomeronasal 1 receptor 110 pseudogene

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE77108 saha 6 v 2 human dn

A Gene Set from LINCS

GSE190076 H-7 Huh-7 0 v 1 human up

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 5 human up

A Gene Set from LINCS

GSE226525 GSE226527 HNRNPH2 knockout 4 v 1 human up

A Gene Set from LINCS

GSE212330 azacitidine 1 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.